Chemocentryx reported $76.08M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
AstraZeneca AZN:LN 1791796.84M 60282.28M
Bayer BAYN:GR € 33643M 2624M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Chemocentryx CCXI:US $ 76.08M 7.27M
GlaxoSmithKline GSK:LN 3783500M 1355700M
Glaxosmithkline GSK:US $ 37835M 13557M
Macrogenics MGNX:US $ 50.88M 16.22M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Novartis NOVN:VX SF 27646M 2161M
Omeros OMER:US $ 38.5M 3.44M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Takeda 4502:JP Y 2166942M 21212M
Teva Pharmaceutical TEVA:IT 11B 617M
YTE INCY:US $ 926.67M 40.51M